{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:38:55Z","timestamp":1792273135233,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jconrel.2024.07.012","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T20:20:58Z","timestamp":1720556458000},"page":"874-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization"],"prefix":"10.1016","volume":"372","author":[{"given":"Yongguo","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangjia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.07.012_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.012_bb0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10717544.2021.2021323","article-title":"Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation","volume":"29","author":"Ma","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis. (Lond)."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.012_bb0020","first-page":"1003","article-title":"The molecular mechanisms of action of PPAR-\u03b3 agonists in the treatment of corneal alkali burns (review)","volume":"38","author":"Zhou","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.012_bb0025","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1167\/iovs.10-6167","article-title":"Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model","volume":"52","author":"Kubota","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0030","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejpb.2020.08.022","article-title":"In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model","volume":"155","author":"Chan","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.jconrel.2024.07.012_bb0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2024.07.012_bb0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","article-title":"Ocular drug delivery: a comprehensive review","volume":"24","author":"Ahmed","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2024.07.012_bb0045","article-title":"Targeted dexamethasone nano-prodrug for corneal neovascularization management","author":"Yin","year":"2023","journal-title":"Biom. J."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0050","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jconrel.2023.07.036","article-title":"Inflammation-responsive molecular-gated contact lens for the treatment of corneal neovascularization","volume":"360","author":"Sun","year":"2023","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.012_bb0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/gels9040292","article-title":"Advances in nanogels for topical drug delivery in ocular diseases","volume":"9","author":"Wu","year":"2023","journal-title":"Gels"},{"issue":"33","key":"10.1016\/j.jconrel.2024.07.012_bb0060","doi-asserted-by":"crossref","first-page":"17411","DOI":"10.1039\/D0NR03095C","article-title":"Nucleic acid peptide nanogels for the treatment of bacterial keratitis","volume":"12","author":"Obuobi","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2024.07.012_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110726","article-title":"Nanoscale poly(acrylic acid)-based hydrogels prepared via a green single-step approach for application as low-viscosity biomimetic fluid tears","volume":"110","author":"Swilem","year":"2020","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.jconrel.2024.07.012_bb0070","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41467-023-44662-5","article-title":"Targeted therapies of inflammatory diseases with intracellularly gelated macrophages in mice and rats","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jconrel.2023.12.033","article-title":"Tumor microenvironment targeting for glioblastoma multiforme treatment via hybrid cell membrane coating supramolecular micelles","volume":"366","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"issue":"32","key":"10.1016\/j.jconrel.2024.07.012_bb0080","doi-asserted-by":"crossref","first-page":"28665","DOI":"10.1021\/acsami.9b09059","article-title":"Host-guest interactions initiated supramolecular chitosan nanogels for selective intracellular drug delivery","volume":"11","author":"Ding","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"14","key":"10.1016\/j.jconrel.2024.07.012_bb0085","article-title":"Long-acting protective ocular surface by instilling adhesive dual-antiviral nanoparticles","volume":"11","author":"Wang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.012_bb0090","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1038\/ncb0402-e65","article-title":"Networks and crosstalk: integrin signalling spreads","volume":"4","author":"Schwartz","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.jconrel.2024.07.012_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat2297","article-title":"Magnetism and photo dual-controlled supramolecular assembly for suppression of tumor invasion and metastasis","volume":"4","author":"Yu","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0100","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.actbio.2023.03.039","article-title":"Hyaluronic acid-based supramolecular nanomedicine with optimized ratio of oxaliplatin\/chlorin e6 for combined chemotherapy and O2-economized photodynamic therapy","volume":"164","author":"Ding","year":"2023","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.jconrel.2024.07.012_bb0105","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-015-2954-x","article-title":"Transplantation of PEDF-transfected pigment epithelial cells inhibits corneal neovascularization in a rabbit model","volume":"253","author":"Kuerten","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108526","article-title":"Long term observation of ocular surface alkali burn in rabbit models: quantitative analysis of corneal haze, vascularity and self-recovery","volume":"205","author":"Kethiri","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"43","key":"10.1016\/j.jconrel.2024.07.012_bb0115","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1039\/C9TB01066A","article-title":"Cytocompatible cerium oxide-mediated antioxidative stress in inhibiting ocular inflammation-associated corneal neovascularization","volume":"7","author":"Zheng","year":"2019","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"10.1016\/j.jconrel.2024.07.012_bb0120","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1167\/iovs.19-27591","article-title":"Repeat corneal neovascularization is characterized by more aggressive inflammation and vessel invasion than in the initial phase","volume":"60","author":"Mukwaya","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"15","key":"10.1016\/j.jconrel.2024.07.012_bb0125","doi-asserted-by":"crossref","first-page":"7986","DOI":"10.3390\/ijms22157986","article-title":"Dexamethasone inhibits the pro-angiogenic potential of primary human myoblasts","volume":"22","author":"Langendorf","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109443","article-title":"Standardization of corneal alkali burn methodology in rabbits","volume":"230","author":"Villabona-Martinez","year":"2023","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0135","article-title":"Targeted dexamethasone nano-prodrug for corneal neovascularization management","author":"Yin","year":"2023","journal-title":"Biom. J."},{"issue":"5","key":"10.1016\/j.jconrel.2024.07.012_bb0140","first-page":"768","article-title":"Molecular underpinnings of corneal angiogenesis: advances over the past decade","volume":"9","author":"Abdelfattah","year":"2016","journal-title":"Int. J. Ophthalmol."},{"issue":"4","key":"10.1016\/j.jconrel.2024.07.012_bb0145","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0150","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2147\/DDDT.S175297","article-title":"The long-term effect of tacrolimus on alkali burn-induced corneal neovascularization and inflammation surpasses that of anti-vascular endothelial growth factor","volume":"12","author":"Chen","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jconrel.2024.07.012_bb0155","article-title":"Laquinimod inhibits inflammation-induced angiogenesis in the cornea","volume":"7","author":"Li","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jconrel.2024.07.012_bb0160","article-title":"Targeted dexamethasone nano-prodrug for corneal neovascularization management","author":"Yin","year":"2023","journal-title":"Biom. J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924004437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T15:33:53Z","timestamp":1721921633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924004437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":32,"alternative-id":["S0168365924004437"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}